These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9566461)

  • 21. Appropriate econometric methods for pharmacoeconometric studies of retrospective claims data: an introductory guide.
    Hay JW
    J Manag Care Pharm; 2005 May; 11(4):344-8. PubMed ID: 15871646
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of technology assessment in health benefits coverage for medical devices.
    Braslow NM; Shatin D; McCarthy DB; Newcomer LN
    Am J Manag Care; 1998 Sep; 4 Spec No():SP139-50. PubMed ID: 10185990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of embolic stroke as a medical emergency. Implications in a managed care environment.
    Lanzieri CF
    Neurosurg Clin N Am; 1997 Apr; 8(2):253-62. PubMed ID: 9113707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive modeling, sharp lens on near future.
    Carlson B
    Manag Care; 2003 Jul; 12(7):16-21. PubMed ID: 12891950
    [No Abstract]   [Full Text] [Related]  

  • 25. The comforts of home.
    Edlin M
    Healthplan; 1996; 37(6):54-8. PubMed ID: 10162986
    [No Abstract]   [Full Text] [Related]  

  • 26. The impact of Medicaid managed care on the uninsured.
    Harv Law Rev; 1997 Jan; 110(3):751-68. PubMed ID: 10169710
    [No Abstract]   [Full Text] [Related]  

  • 27. Cost benefits of picture archiving and communications systems.
    Arenson RL; Burnside ES; Avrin DE; Gould RG; Huang HK; Marco RP
    Acad Radiol; 1996 Apr; 3 Suppl 1():S72-4. PubMed ID: 8796520
    [No Abstract]   [Full Text] [Related]  

  • 28. Health care in the 21st century: evidence-based medicine, patient preference-based quality, and cost effectiveness.
    Brown GC; Brown MM; Sharma S
    Qual Manag Health Care; 2000; 9(1):23-31. PubMed ID: 11185879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing technological explosion in the medical management of coronary artery disease, Part II. DES economic modeling: budgeting strategies for drug-eluting stent technology.
    Chumer K; DeCerce J; Vaul J
    J Cardiovasc Manag; 2002; 13(4):16-20. PubMed ID: 12192774
    [No Abstract]   [Full Text] [Related]  

  • 30. Managed care programs: an employer perspective.
    Carroll MS
    Top Health Care Financ; 1993; 20(2):10-6. PubMed ID: 8310429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of pharmacoeconomics to formulary decision making in managed care organizations.
    Suh DC; Okpara IR; Agnese WB; Toscani M
    Am J Manag Care; 2002 Feb; 8(2):161-9. PubMed ID: 11858228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health care 2000: top 10 trends for the new century.
    Coile RC
    Russ Coiles Health Trends; 2000 Jan; 12(3):1, 4-12. PubMed ID: 10747683
    [No Abstract]   [Full Text] [Related]  

  • 33. Managed care: has the revolution arrived?
    Lewis TS
    Med Device Technol; 1998 Mar; 9(2):42-8. PubMed ID: 10186977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opportunities in managed care.
    McGee MD
    Psychiatr Serv; 1997 Jun; 48(6):739. PubMed ID: 9175180
    [No Abstract]   [Full Text] [Related]  

  • 35. [The value of pharmaco-economics: the point of view of the drug industry].
    De Wever A
    Rev Med Liege; 1998 May; 53(5):236-41. PubMed ID: 9689874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amnesia. When it comes to health care, Americans seem to have forgotten the lessons of the recent past.
    Millenson M
    Healthplan; 1998; 39(5):52-8. PubMed ID: 10351336
    [No Abstract]   [Full Text] [Related]  

  • 37. Is there a role for pharmacoeconomics in developing countries?
    Harper JR
    Pharmacoeconomics; 2011 May; 29(5):435-6; author reply 436-7. PubMed ID: 21504243
    [No Abstract]   [Full Text] [Related]  

  • 38. Cost-effective use of NSAIDs: issues pertinent to coxib use in managed care.
    Fendrick AM
    Am J Manag Care; 2002 Nov; 8(17 Suppl):S529-41. PubMed ID: 12458822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and economic considerations of coronary heart disease: a managed care approach. Proceedings based on presentations from two conferences, Cardiovascular Event Reduction: Defining the Role of HMG Therapy in Managed Care, held November 14-16, 1997 in Philadelphia, and Pharmacoeconomics & Outcomes Issues of Lipid Therapy, held November 5-7, 1997 in Orlando.
    Am J Manag Care; 1998 Apr; 4(4 Suppl):S168-233. PubMed ID: 10180343
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacoeconomics and health policy. Current applications and prospects for the future.
    Greenberg PE; Arcelus A; Birnbaum HG; Cremieux PY; LeLorier J; Ouellette P; Slavin MB
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 1):425-32. PubMed ID: 10662390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.